Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12615000385549
Ethics application status
Approved
Date submitted
5/03/2015
Date registered
28/04/2015
Date last updated
9/04/2018
Type of registration
Prospectively registered
Titles & IDs
Public title
Profiling bioavailable berry polyphenols in humans
Query!
Scientific title
Profiling of specific berry-fruit derived polyphenol metabolites in plasma and urine of healthy adult humans fed blueberry or boysenberry extract
Query!
Secondary ID [1]
286319
0
Nil
Query!
Universal Trial Number (UTN)
U1111-1167-4904
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
General Health and wellbeing
294416
0
Query!
Cardiovascular Disease
294484
0
Query!
Condition category
Condition code
Public Health
294725
294725
0
0
Query!
Other public health
Query!
Cardiovascular
294788
294788
0
0
Query!
Normal development and function of the cardiovascular system
Query!
Cardiovascular
294790
294790
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Arm 1: Blueberry extract
Arm 2: Boysenberry extract
Special Note: We have reconsidered the use of whole fruit and have excluded this from the current protocol. An extract of the fruit only will be used and this will be administered in 250 mL liquid form.
Intervention details
Dose: 250 mL extract of blueberry or boysenberry
Duration: One-off administration
Lead-in dietary washout phase: Up to 1-week of low polyphenol diet
Mode of administration: Oral
Samples collected: Baseline (overnight-fasted), and postprandial (0.5, 1, 2, 4, 6, 8, 9, 12, and 24h) blood samples, and, 0-24 h urine samples
Analytical technique: High performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) for compliance check and detection, identification, and quantification of selected juice-derived polyphenol metabolites
Query!
Intervention code [1]
291362
0
Treatment: Other
Query!
Comparator / control treatment
No control treatment
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
294488
0
Precise identities and circulating concentrations of berry-fruit derived polyphenol metabolites established in postprandial plasma and urine after intake of blueberry or boysenberry extract
Query!
Assessment method [1]
294488
0
Query!
Timepoint [1]
294488
0
At baseline (After overnight fast), 0.5, 1, 2, 4, 6, 8, 9, 12, and 24 hours after intake of blueberry or boysenberry extract
Query!
Secondary outcome [1]
313439
0
Not applicable
Query!
Assessment method [1]
313439
0
Query!
Timepoint [1]
313439
0
Not applicable
Query!
Eligibility
Key inclusion criteria
Healthy males/females aged 18 or older, non-smokers, non-pregnant, and residing in Auckland for the duration of the study.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Declare themselves unhealthy, drink alcohol excessively, are (or are seeking to become) pregnant, are currently taking recreation/over-the-counter/prescription medication (excluding contraceptive pills and other select pills)/dietary and herbal supplements, have any food allergies or sensitivities, have a history of/current head trauma, ADHD (Attention Deficient Hyperactivity Disorder), dyslexia, migraines or any gastric problems, have a history of eating disorders (anorexia nervosa, bulimia, etc.), suffer from or have a history of clinical hypertension, have a BMI over 39 (morbidly obese), have fainting issues due to venipuncture, do not have good understanding of English
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/05/2015
Query!
Actual
20/05/2015
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
21/11/2015
Query!
Date of last data collection
Anticipated
Query!
Actual
15/06/2016
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
5
Query!
Recruitment outside Australia
Country [1]
6719
0
New Zealand
Query!
State/province [1]
6719
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
290890
0
University
Query!
Name [1]
290890
0
Auckland Uniservices Ltd. (The University of Auckland)
Query!
Address [1]
290890
0
Auckland Uniservices Limited, Private Bag 92019, Victoria Street West, Auckland 1142, New Zealand
Query!
Country [1]
290890
0
New Zealand
Query!
Primary sponsor type
University
Query!
Name
The University of Auckland
Query!
Address
Research Integrity Unit (Building 620),
49 Symonds Street, Level 10,
Auckland 1142
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
289571
0
Other Collaborative groups
Query!
Name [1]
289571
0
Centre for Free Radical Research (University of Otago)
Query!
Address [1]
289571
0
Centre for Free Radical Research
University of Otago, Christchurch
2 Riccarton Ave
Christchurch 8011
Query!
Country [1]
289571
0
New Zealand
Query!
Other collaborator category [1]
278388
0
Individual
Query!
Name [1]
278388
0
Dr. Arjan Scheepens
Query!
Address [1]
278388
0
Plant and Food Research
120 Mt Albert Road, Sandringham, Auckland 1025
Query!
Country [1]
278388
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
292490
0
Health and Disability Ethics Committees (HDEC)
Query!
Ethics committee address [1]
292490
0
Ministry of Health Ethics Department Reception - Ground Floor 20 Aitken Street Thorndon WELLINGTON, 6011
Query!
Ethics committee country [1]
292490
0
New Zealand
Query!
Date submitted for ethics approval [1]
292490
0
06/03/2015
Query!
Approval date [1]
292490
0
13/04/2015
Query!
Ethics approval number [1]
292490
0
15/NTA/46
Query!
Summary
Brief summary
Preliminary evidence from human intervention studies support a potential role of berries and their processed products in risks mitigation of inflammatory diseases (Joseph et al., 2014) and cardiovascular diseases (CVDs) (Rodriguez-Mateos et al., 2014). Despite these, owing to limited studies that assessed the absorption and metabolism of berry (poly)phenols, at present, it remains unclear whether it is the native (unmetabolized) berry polyphenols, their in vivo metabolic breakdown products, or a combination of the two, that are responsible for attributing the cardiovascular health benefits associated with consumption of berry products. As such, to enable the establishment of potential cause-and-effect relationships, the current literature recommends the need for more research efforts to clarify which specific berry (poly)phenols are directly responsible for the observed in vivo beneficial actions on cardiovascular health. In addition, it is unclear whether consumption of berry species with some subtle differences in (poly)phenol composition would give rise to some common in vivo plasma and/or urinary metabolite profiles. This information is critical as it would help explain whether observed differences in some measurable clinical endpoints of CVDs derived from consumption of different berry species is fundamentally associated to differences in the in vivo (poly)phenol metabolite profiles. Our Hypothesis: Based on information from the current literature, we hypothesize that some (poly)phenolic breakdown products are common in vivo metabolites that are formed postprandially, regardless of subtle differences in berry (poly)phenol composition, and that these (poly)phenolic metabolites (as opposed to the native polyphenols found in berry extracts) are partly responsible for upregulating in vivo mechanisms that lead towards some measurable beneficial cardiovascular health outcomes in humans.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
55574
0
Prof Margreet Vissers
Query!
Address
55574
0
Centre for Free Radical Research,
University of Otago,
2 Riccarton Ave,
Christchurch 8011, New Zealand
Query!
Country
55574
0
New Zealand
Query!
Phone
55574
0
+64 3 364 1524
Query!
Fax
55574
0
Query!
Email
55574
0
[email protected]
Query!
Contact person for public queries
Name
55575
0
Margreet Vissers
Query!
Address
55575
0
Centre for Free Radical Research,
University of Otago,
2 Riccarton Ave,
Christchurch 8011, New Zealand
Query!
Country
55575
0
New Zealand
Query!
Phone
55575
0
+64 3 364 1524
Query!
Fax
55575
0
Query!
Email
55575
0
[email protected]
Query!
Contact person for scientific queries
Name
55576
0
Margreet Vissers
Query!
Address
55576
0
Centre for Free Radical Research,
University of Otago,
2 Riccarton Ave,
Christchurch 8011, New Zealand
Query!
Country
55576
0
New Zealand
Query!
Phone
55576
0
+64 3 364 1524
Query!
Fax
55576
0
Query!
Email
55576
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF